News & Events
16 May 2022
7th Consortium Meeting in Stockholm On the 9th & 10th of May we met in Stockholm for the 7th PREFERABLE Consortium Meeting.
READ MORE6 April 2022
Over 300 participants in EFFECT trial This week we reached a number of over 300 participants in the EFFECT trial. In total we aim for 350 participants, which we expect to reach this summer.
READ MORE2 November 2021
200th participant included! We have now included our 200th participant in the EFFECT trial!
READ MORECollaboration
PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.
